Abeona Therapeutics Q3 EPS $(0.35) Down From $(0.34) YoY; Cash And Cash Equivalents As Of Sept. 30 $47.9M

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.35) per share. This is a 2.94 percent decrease over losses of $(0.34) per share from the same period last year.

Benzinga · 11/12/2019 21:48

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.35) per share. This is a 2.94 percent decrease over losses of $(0.34) per share from the same period last year.